Maravai LifeSciences Holdings Inc. Class A Common Stock vs VanEck Semiconductor ETF — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while VanEck Semiconductor ETF trades at $553.65 (market cap $71.21B). The key difference: VanEck Semiconductor ETF is far larger — about 72.9× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and VanEck Semiconductor ETF is more actively traded (11,805,201 versus 2,742,564). Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and VanEck Semiconductor ETF for 102 Days on average.
| MRVI | SMH | |
|---|---|---|
Market Cap | $977.37M | $71.21B |
Volume | 2,742,564 | 11,805,201 |
Sector | Health | — |
52-Week High | $9.00 | $668.91 |
52-Week Low | $2.83 | $325.10 |
Typical Hold Time | 0 Days | 102 Days |
Enterprise Value | $1.08B | — |
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
SMH (VanEck Semiconductor ETF) trades at $588.12, down 0.49% on the day, with technical indicators showing mixed signals - a bullish overall signal but bearish moving averages. The semiconductor sector has been a standout performer in 2026, with SMH delivering approximately 69% returns year-to-date according to The Motley Fool (2026-10-01). Recent sector strength is supported by AI-driven demand and major acquisitions like AMD's $8.2 billion World Labs purchase.
The semiconductor ETF offers diversified exposure to the AI hardware boom, though concentration in top holdings like Nvidia presents both opportunity and risk. Sector rotation concerns and valuation pressures after strong gains represent near-term headwinds, while long-term growth prospects remain favorable given Bank of America's projection of near-doubling global chip market by 2030.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →